| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |